STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma.
Saved in:
| Title: | STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma. |
|---|---|
| Authors: | Zhang L; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Nesvick CL; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Day CA; Section of Cellular Dynamics, The Hormel Institute, University of Minnesota, Austin, Minnesota, USA., Choi J; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Lu VM; Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA., Peterson T; Department of Cardiac Regeneration Program, Mayo Clinic, Rochester, Minnesota, USA., Power EA; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, USA., Anderson JB; Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic College of Medicine and Science Medical Scientist Training Program, Rochester, MN, USA., Hamdan FH; Department of Gastroenterology, Mayo Clinic, Rochester, Minnesota, USA., Decker PA; Department of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA., Simons R; Campbell University Jerry M. Wallace School of Osteopathic Medicine, Buies Creek, North Carolina, USA., Welby JP; Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Siada R; Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Ge J; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Kaptzan T; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Johnsen SA; Department of Gastroenterology, Mayo Clinic, Rochester, Minnesota, USA.; Robert Bosch Center for Tumor Diseases, Stuttgart, Germany., Hinchcliffe EH; Section of Cellular Dynamics, The Hormel Institute, University of Minnesota, Austin, Minnesota, USA., Daniels DJ; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.; Molecular Pharmacology and Experimental Therapeutics Program, Mayo Clinic, Rochester, Minnesota, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2022 Oct 03; Vol. 24 (10), pp. 1700-1711. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noac093 |
